Taxanes inhibit human TLR4 signaling by binding to MD-2

Area of Science:

• Immunology
• Pharmacology
• Structural Biology

Background:

• Lipopolysaccharide (LPS) is a primary ligand for Toll-like receptor 4 (TLR4).
• TLR4 activation by LPS involves its accessory protein, MD-2.
• Paclitaxel activates murine MD-2/TLR4 but not human MD-2/TLR4.

Purpose of the Study:

• To investigate the interaction of paclitaxel with human MD-2.
• To elucidate the mechanism by which taxanes inhibit LPS signaling in human TLR4 systems.
• To understand the structural basis for differential activation of MD-2/TLR4 by paclitaxel.

Main Methods:

• Molecular docking studies to identify binding sites and interactions.
• Circular dichroism spectroscopy to analyze changes in MD-2.
• Biochemical assays to assess inhibition of LPS signaling.

Main Results:

• Paclitaxel binds to human MD-2, with its binding site overlapping that of LPS.
• Taxanes, including paclitaxel and docetaxel, inhibit LPS signaling through human TLR4.
• Circular dichroism revealed distinct chemical environment changes in human MD-2 upon paclitaxel and docetaxel binding.
• Molecular docking indicated hydrophobic interactions are key for binding, with the C-3'N group exposed.

Conclusions:

• Paclitaxel's interaction with human MD-2 is crucial for its inhibitory effect on LPS-induced TLR4 signaling.
• Structural differences in MD-2 binding explain the differential activation of TLR4 by paclitaxel in murine versus human systems.
• Taxanes represent a potential therapeutic strategy for modulating TLR4-mediated inflammatory responses.